Request for Covid-19 Impact Assessment of this Report
The United States Antimicrobial Peptides market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Antimicrobial Peptides market, reaching US$ million by the year 2028. As for the Europe Antimicrobial Peptides landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Antimicrobial Peptides players cover AnaSpec, AMP Biotech, Phoenix Biotech, and Novabiotics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Antimicrobial Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pharmaceuticals
Feed Additives
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antimicrobial Peptides Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Antimicrobial Peptides by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Antimicrobial Peptides by Country/Region, 2017, 2022 & 2028
2.2 Antimicrobial Peptides Segment by Type
2.2.1 Plant Antimicrobial Peptides
2.2.2 Microbial Antimicrobial Peptides
2.2.3 Animal Antimicrobial Peptides
2.3 Antimicrobial Peptides Sales by Type
2.3.1 Global Antimicrobial Peptides Sales Market Share by Type (2017-2022)
2.3.2 Global Antimicrobial Peptides Revenue and Market Share by Type (2017-2022)
2.3.3 Global Antimicrobial Peptides Sale Price by Type (2017-2022)
2.4 Antimicrobial Peptides Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Feed Additives
2.4.3 Others
2.5 Antimicrobial Peptides Sales by Application
2.5.1 Global Antimicrobial Peptides Sale Market Share by Application (2017-2022)
2.5.2 Global Antimicrobial Peptides Revenue and Market Share by Application (2017-2022)
2.5.3 Global Antimicrobial Peptides Sale Price by Application (2017-2022)
3 Global Antimicrobial Peptides by Company
3.1 Global Antimicrobial Peptides Breakdown Data by Company
3.1.1 Global Antimicrobial Peptides Annual Sales by Company (2020-2022)
3.1.2 Global Antimicrobial Peptides Sales Market Share by Company (2020-2022)
3.2 Global Antimicrobial Peptides Annual Revenue by Company (2020-2022)
3.2.1 Global Antimicrobial Peptides Revenue by Company (2020-2022)
3.2.2 Global Antimicrobial Peptides Revenue Market Share by Company (2020-2022)
3.3 Global Antimicrobial Peptides Sale Price by Company
3.4 Key Manufacturers Antimicrobial Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antimicrobial Peptides Product Location Distribution
3.4.2 Players Antimicrobial Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antimicrobial Peptides by Geographic Region
4.1 World Historic Antimicrobial Peptides Market Size by Geographic Region (2017-2022)
4.1.1 Global Antimicrobial Peptides Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Antimicrobial Peptides Annual Revenue by Geographic Region
4.2 World Historic Antimicrobial Peptides Market Size by Country/Region (2017-2022)
4.2.1 Global Antimicrobial Peptides Annual Sales by Country/Region (2017-2022)
4.2.2 Global Antimicrobial Peptides Annual Revenue by Country/Region
4.3 Americas Antimicrobial Peptides Sales Growth
4.4 APAC Antimicrobial Peptides Sales Growth
4.5 Europe Antimicrobial Peptides Sales Growth
4.6 Middle East & Africa Antimicrobial Peptides Sales Growth
5 Americas
5.1 Americas Antimicrobial Peptides Sales by Country
5.1.1 Americas Antimicrobial Peptides Sales by Country (2017-2022)
5.1.2 Americas Antimicrobial Peptides Revenue by Country (2017-2022)
5.2 Americas Antimicrobial Peptides Sales by Type
5.3 Americas Antimicrobial Peptides Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antimicrobial Peptides Sales by Region
6.1.1 APAC Antimicrobial Peptides Sales by Region (2017-2022)
6.1.2 APAC Antimicrobial Peptides Revenue by Region (2017-2022)
6.2 APAC Antimicrobial Peptides Sales by Type
6.3 APAC Antimicrobial Peptides Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antimicrobial Peptides by Country
7.1.1 Europe Antimicrobial Peptides Sales by Country (2017-2022)
7.1.2 Europe Antimicrobial Peptides Revenue by Country (2017-2022)
7.2 Europe Antimicrobial Peptides Sales by Type
7.3 Europe Antimicrobial Peptides Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antimicrobial Peptides by Country
8.1.1 Middle East & Africa Antimicrobial Peptides Sales by Country (2017-2022)
8.1.2 Middle East & Africa Antimicrobial Peptides Revenue by Country (2017-2022)
8.2 Middle East & Africa Antimicrobial Peptides Sales by Type
8.3 Middle East & Africa Antimicrobial Peptides Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antimicrobial Peptides
10.3 Manufacturing Process Analysis of Antimicrobial Peptides
10.4 Industry Chain Structure of Antimicrobial Peptides
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antimicrobial Peptides Distributors
11.3 Antimicrobial Peptides Customer
12 World Forecast Review for Antimicrobial Peptides by Geographic Region
12.1 Global Antimicrobial Peptides Market Size Forecast by Region
12.1.1 Global Antimicrobial Peptides Forecast by Region (2023-2028)
12.1.2 Global Antimicrobial Peptides Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antimicrobial Peptides Forecast by Type
12.7 Global Antimicrobial Peptides Forecast by Application
13 Key Players Analysis
13.1 AnaSpec
13.1.1 AnaSpec Company Information
13.1.2 AnaSpec Antimicrobial Peptides Product Offered
13.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AnaSpec Main Business Overview
13.1.5 AnaSpec Latest Developments
13.2 AMP Biotech
13.2.1 AMP Biotech Company Information
13.2.2 AMP Biotech Antimicrobial Peptides Product Offered
13.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AMP Biotech Main Business Overview
13.2.5 AMP Biotech Latest Developments
13.3 Phoenix Biotech
13.3.1 Phoenix Biotech Company Information
13.3.2 Phoenix Biotech Antimicrobial Peptides Product Offered
13.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Phoenix Biotech Main Business Overview
13.3.5 Phoenix Biotech Latest Developments
13.4 Novabiotics
13.4.1 Novabiotics Company Information
13.4.2 Novabiotics Antimicrobial Peptides Product Offered
13.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novabiotics Main Business Overview
13.4.5 Novabiotics Latest Developments
13.5 Chinese Peptide
13.5.1 Chinese Peptide Company Information
13.5.2 Chinese Peptide Antimicrobial Peptides Product Offered
13.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Chinese Peptide Main Business Overview
13.5.5 Chinese Peptide Latest Developments
13.6 Ontores
13.6.1 Ontores Company Information
13.6.2 Ontores Antimicrobial Peptides Product Offered
13.6.3 Ontores Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ontores Main Business Overview
13.6.5 Ontores Latest Developments
13.7 GenScript
13.7.1 GenScript Company Information
13.7.2 GenScript Antimicrobial Peptides Product Offered
13.7.3 GenScript Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 GenScript Main Business Overview
13.7.5 GenScript Latest Developments
13.8 Hycult Biotech
13.8.1 Hycult Biotech Company Information
13.8.2 Hycult Biotech Antimicrobial Peptides Product Offered
13.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hycult Biotech Main Business Overview
13.8.5 Hycult Biotech Latest Developments
13.9 Sunsmile
13.9.1 Sunsmile Company Information
13.9.2 Sunsmile Antimicrobial Peptides Product Offered
13.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sunsmile Main Business Overview
13.9.5 Sunsmile Latest Developments
13.10 Ruixing Biotechnology
13.10.1 Ruixing Biotechnology Company Information
13.10.2 Ruixing Biotechnology Antimicrobial Peptides Product Offered
13.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Ruixing Biotechnology Main Business Overview
13.10.5 Ruixing Biotechnology Latest Developments
13.11 Zhongnong Yingtai Biotechnology
13.11.1 Zhongnong Yingtai Biotechnology Company Information
13.11.2 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Offered
13.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Zhongnong Yingtai Biotechnology Main Business Overview
13.11.5 Zhongnong Yingtai Biotechnology Latest Developments
13.12 Glam Technology
13.12.1 Glam Technology Company Information
13.12.2 Glam Technology Antimicrobial Peptides Product Offered
13.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Glam Technology Main Business Overview
13.12.5 Glam Technology Latest Developments
13.13 ProteLight Pharmaceutical & Biotechnology
13.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
13.13.2 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Offered
13.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 ProteLight Pharmaceutical & Biotechnology Main Business Overview
13.13.5 ProteLight Pharmaceutical & Biotechnology Latest Developments
14 Research Findings and Conclusion
Table 1. Antimicrobial Peptides Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antimicrobial Peptides Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Plant Antimicrobial Peptides
Table 4. Major Players of Microbial Antimicrobial Peptides
Table 5. Major Players of Animal Antimicrobial Peptides
Table 6. Global Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 7. Global Antimicrobial Peptides Sales Market Share by Type (2017-2022)
Table 8. Global Antimicrobial Peptides Revenue by Type (2017-2022) & ($ million)
Table 9. Global Antimicrobial Peptides Revenue Market Share by Type (2017-2022)
Table 10. Global Antimicrobial Peptides Sale Price by Type (2017-2022) & (US$/Mg)
Table 11. Global Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 12. Global Antimicrobial Peptides Sales Market Share by Application (2017-2022)
Table 13. Global Antimicrobial Peptides Revenue by Application (2017-2022)
Table 14. Global Antimicrobial Peptides Revenue Market Share by Application (2017-2022)
Table 15. Global Antimicrobial Peptides Sale Price by Application (2017-2022) & (US$/Mg)
Table 16. Global Antimicrobial Peptides Sales by Company (2020-2022) & (Mg)
Table 17. Global Antimicrobial Peptides Sales Market Share by Company (2020-2022)
Table 18. Global Antimicrobial Peptides Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Antimicrobial Peptides Revenue Market Share by Company (2020-2022)
Table 20. Global Antimicrobial Peptides Sale Price by Company (2020-2022) & (US$/Mg)
Table 21. Key Manufacturers Antimicrobial Peptides Producing Area Distribution and Sales Area
Table 22. Players Antimicrobial Peptides Products Offered
Table 23. Antimicrobial Peptides Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Antimicrobial Peptides Sales by Geographic Region (2017-2022) & (Mg)
Table 27. Global Antimicrobial Peptides Sales Market Share Geographic Region (2017-2022)
Table 28. Global Antimicrobial Peptides Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Antimicrobial Peptides Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Antimicrobial Peptides Sales by Country/Region (2017-2022) & (Mg)
Table 31. Global Antimicrobial Peptides Sales Market Share by Country/Region (2017-2022)
Table 32. Global Antimicrobial Peptides Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Antimicrobial Peptides Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 35. Americas Antimicrobial Peptides Sales Market Share by Country (2017-2022)
Table 36. Americas Antimicrobial Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Antimicrobial Peptides Revenue Market Share by Country (2017-2022)
Table 38. Americas Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 39. Americas Antimicrobial Peptides Sales Market Share by Type (2017-2022)
Table 40. Americas Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 41. Americas Antimicrobial Peptides Sales Market Share by Application (2017-2022)
Table 42. APAC Antimicrobial Peptides Sales by Region (2017-2022) & (Mg)
Table 43. APAC Antimicrobial Peptides Sales Market Share by Region (2017-2022)
Table 44. APAC Antimicrobial Peptides Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Antimicrobial Peptides Revenue Market Share by Region (2017-2022)
Table 46. APAC Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 47. APAC Antimicrobial Peptides Sales Market Share by Type (2017-2022)
Table 48. APAC Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 49. APAC Antimicrobial Peptides Sales Market Share by Application (2017-2022)
Table 50. Europe Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 51. Europe Antimicrobial Peptides Sales Market Share by Country (2017-2022)
Table 52. Europe Antimicrobial Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Antimicrobial Peptides Revenue Market Share by Country (2017-2022)
Table 54. Europe Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 55. Europe Antimicrobial Peptides Sales Market Share by Type (2017-2022)
Table 56. Europe Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 57. Europe Antimicrobial Peptides Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Antimicrobial Peptides Sales by Country (2017-2022) & (Mg)
Table 59. Middle East & Africa Antimicrobial Peptides Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Antimicrobial Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Antimicrobial Peptides Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Antimicrobial Peptides Sales by Type (2017-2022) & (Mg)
Table 63. Middle East & Africa Antimicrobial Peptides Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Antimicrobial Peptides Sales by Application (2017-2022) & (Mg)
Table 65. Middle East & Africa Antimicrobial Peptides Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Antimicrobial Peptides
Table 67. Key Market Challenges & Risks of Antimicrobial Peptides
Table 68. Key Industry Trends of Antimicrobial Peptides
Table 69. Antimicrobial Peptides Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Antimicrobial Peptides Distributors List
Table 72. Antimicrobial Peptides Customer List
Table 73. Global Antimicrobial Peptides Sales Forecast by Region (2023-2028) & (Mg)
Table 74. Global Antimicrobial Peptides Sales Market Forecast by Region
Table 75. Global Antimicrobial Peptides Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Antimicrobial Peptides Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Antimicrobial Peptides Sales Forecast by Country (2023-2028) & (Mg)
Table 78. Americas Antimicrobial Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Antimicrobial Peptides Sales Forecast by Region (2023-2028) & (Mg)
Table 80. APAC Antimicrobial Peptides Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Antimicrobial Peptides Sales Forecast by Country (2023-2028) & (Mg)
Table 82. Europe Antimicrobial Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Antimicrobial Peptides Sales Forecast by Country (2023-2028) & (Mg)
Table 84. Middle East & Africa Antimicrobial Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Antimicrobial Peptides Sales Forecast by Type (2023-2028) & (Mg)
Table 86. Global Antimicrobial Peptides Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Antimicrobial Peptides Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Antimicrobial Peptides Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Antimicrobial Peptides Sales Forecast by Application (2023-2028) & (Mg)
Table 90. Global Antimicrobial Peptides Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Antimicrobial Peptides Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Antimicrobial Peptides Revenue Market Share Forecast by Application (2023-2028)
Table 93. AnaSpec Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 94. AnaSpec Antimicrobial Peptides Product Offered
Table 95. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 96. AnaSpec Main Business
Table 97. AnaSpec Latest Developments
Table 98. AMP Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 99. AMP Biotech Antimicrobial Peptides Product Offered
Table 100. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 101. AMP Biotech Main Business
Table 102. AMP Biotech Latest Developments
Table 103. Phoenix Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 104. Phoenix Biotech Antimicrobial Peptides Product Offered
Table 105. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 106. Phoenix Biotech Main Business
Table 107. Phoenix Biotech Latest Developments
Table 108. Novabiotics Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 109. Novabiotics Antimicrobial Peptides Product Offered
Table 110. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 111. Novabiotics Main Business
Table 112. Novabiotics Latest Developments
Table 113. Chinese Peptide Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 114. Chinese Peptide Antimicrobial Peptides Product Offered
Table 115. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 116. Chinese Peptide Main Business
Table 117. Chinese Peptide Latest Developments
Table 118. Ontores Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 119. Ontores Antimicrobial Peptides Product Offered
Table 120. Ontores Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 121. Ontores Main Business
Table 122. Ontores Latest Developments
Table 123. GenScript Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 124. GenScript Antimicrobial Peptides Product Offered
Table 125. GenScript Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 126. GenScript Main Business
Table 127. GenScript Latest Developments
Table 128. Hycult Biotech Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 129. Hycult Biotech Antimicrobial Peptides Product Offered
Table 130. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 131. Hycult Biotech Main Business
Table 132. Hycult Biotech Latest Developments
Table 133. Sunsmile Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 134. Sunsmile Antimicrobial Peptides Product Offered
Table 135. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 136. Sunsmile Main Business
Table 137. Sunsmile Latest Developments
Table 138. Ruixing Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 139. Ruixing Biotechnology Antimicrobial Peptides Product Offered
Table 140. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 141. Ruixing Biotechnology Main Business
Table 142. Ruixing Biotechnology Latest Developments
Table 143. Zhongnong Yingtai Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 144. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product Offered
Table 145. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 146. Zhongnong Yingtai Biotechnology Main Business
Table 147. Zhongnong Yingtai Biotechnology Latest Developments
Table 148. Glam Technology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 149. Glam Technology Antimicrobial Peptides Product Offered
Table 150. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 151. Glam Technology Main Business
Table 152. Glam Technology Latest Developments
Table 153. ProteLight Pharmaceutical & Biotechnology Basic Information, Antimicrobial Peptides Manufacturing Base, Sales Area and Its Competitors
Table 154. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product Offered
Table 155. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue ($ Million), Price (US$/Mg) and Gross Margin (2020-2022)
Table 156. ProteLight Pharmaceutical & Biotechnology Main Business
Table 157. ProteLight Pharmaceutical & Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Antimicrobial Peptides
Figure 2. Antimicrobial Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antimicrobial Peptides Sales Growth Rate 2017-2028 (Mg)
Figure 7. Global Antimicrobial Peptides Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antimicrobial Peptides Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Plant Antimicrobial Peptides
Figure 10. Product Picture of Microbial Antimicrobial Peptides
Figure 11. Product Picture of Animal Antimicrobial Peptides
Figure 12. Global Antimicrobial Peptides Sales Market Share by Type in 2021
Figure 13. Global Antimicrobial Peptides Revenue Market Share by Type (2017-2022)
Figure 14. Antimicrobial Peptides Consumed in Pharmaceuticals
Figure 15. Global Antimicrobial Peptides Market: Pharmaceuticals (2017-2022) & (Mg)
Figure 16. Antimicrobial Peptides Consumed in Feed Additives
Figure 17. Global Antimicrobial Peptides Market: Feed Additives (2017-2022) & (Mg)
Figure 18. Antimicrobial Peptides Consumed in Others
Figure 19. Global Antimicrobial Peptides Market: Others (2017-2022) & (Mg)
Figure 20. Global Antimicrobial Peptides Sales Market Share by Application (2017-2022)
Figure 21. Global Antimicrobial Peptides Revenue Market Share by Application in 2021
Figure 22. Antimicrobial Peptides Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Antimicrobial Peptides Revenue Market Share by Company in 2021
Figure 24. Global Antimicrobial Peptides Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Antimicrobial Peptides Revenue Market Share by Geographic Region in 2021
Figure 26. Global Antimicrobial Peptides Sales Market Share by Region (2017-2022)
Figure 27. Global Antimicrobial Peptides Revenue Market Share by Country/Region in 2021
Figure 28. Americas Antimicrobial Peptides Sales 2017-2022 (Mg)
Figure 29. Americas Antimicrobial Peptides Revenue 2017-2022 ($ Millions)
Figure 30. APAC Antimicrobial Peptides Sales 2017-2022 (Mg)
Figure 31. APAC Antimicrobial Peptides Revenue 2017-2022 ($ Millions)
Figure 32. Europe Antimicrobial Peptides Sales 2017-2022 (Mg)
Figure 33. Europe Antimicrobial Peptides Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Antimicrobial Peptides Sales 2017-2022 (Mg)
Figure 35. Middle East & Africa Antimicrobial Peptides Revenue 2017-2022 ($ Millions)
Figure 36. Americas Antimicrobial Peptides Sales Market Share by Country in 2021
Figure 37. Americas Antimicrobial Peptides Revenue Market Share by Country in 2021
Figure 38. United States Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Antimicrobial Peptides Sales Market Share by Region in 2021
Figure 43. APAC Antimicrobial Peptides Revenue Market Share by Regions in 2021
Figure 44. China Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Antimicrobial Peptides Sales Market Share by Country in 2021
Figure 51. Europe Antimicrobial Peptides Revenue Market Share by Country in 2021
Figure 52. Germany Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Antimicrobial Peptides Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Antimicrobial Peptides Revenue Market Share by Country in 2021
Figure 59. Egypt Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Antimicrobial Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Antimicrobial Peptides in 2021
Figure 65. Manufacturing Process Analysis of Antimicrobial Peptides
Figure 66. Industry Chain Structure of Antimicrobial Peptides
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...